Literature DB >> 32274552

MR elastography, T1 and T2 relaxometry of liver: role in noninvasive assessment of liver function and portal hypertension.

David H Hoffman1, Abimbola Ayoola2, Dominik Nickel3, Fei Han3, Hersh Chandarana2, James Babb2, Krishna Prasad Shanbhogue2.   

Abstract

PURPOSE: To evaluate the correlation between liver stiffness as measured on MR elastography and T1 and T2 relaxation times from T1 and T2 mapping with clinical parameters of liver disease, including the MELD score, MELD-Na and ALBI grade, and endoscopically visible esophageal varices.
MATERIALS AND METHODS: 223 patients with known or suspected liver disease underwent MRI of the liver with T1 mapping (Look-Locker sequence) and 2D SE-EPI MR elastography (MRE) sequences. 139 of these patients also underwent T2 mapping with radial T2 FS sequence. Two readers measured liver stiffness, T1 relaxation times and T2 relaxation times, and assessed qualitative features such as presence or absence of cirrhosis, ascites, spleen length, and varices on conventional MRI images. A third reader collected the clinical data (MELD score, MELD-Na Score, ALBI grade, and results of endoscopy in 78 patients).
RESULTS: Significant moderate correlation was found between MELD score and all three imaging techniques for both readers (MRE, r = 0.35 and 0.28; T1 relaxometry, r = 0.30 and 0.29; T2 relaxometry, r = 0.45, and 0.37 for reader 1 and reader 2 respectively). Correlation with MELD-Na score was even higher (MRE, r = 0.49 and 0.40; T1, r = 0.45 and 0.41; T2, r = 0.47 and 0.35 for reader 1 and reader 2 respectively). Correlations between MRE and ALBI grade was significant and moderate for both readers: r = 0.39 and 0.37, higher than T1 relaxometry (r = 0.22 and 0.20) and T2 relaxometry (r = 0.17, and r = 0.24). Significant moderate correlations were found for both readers between MRE and the presence of varices on endoscopy (r = 0.28 and 0.30). MRE and T1 relaxometry were significant predictors of varices at endoscopy for both readers (MRE AUC 0.923 and 0.873; T1 relaxometry AUC = 0.711 and 0.675 for reader 1 and reader 2 respectively). Cirrhotic morphology (AUC = 0.654), spleen length (AUC = 0.610) and presence of varices in the upper abdomen on MRI (AUC of 0.693 and 0.595) were all significant predictors of endoscopic varices. Multivariable logistic regression model identified that spleen length and liver MRE were significant independent predictors of endoscopic varices for both readers.
CONCLUSION: MR elastography, T1 and T2 relaxometry demonstrated moderate positive correlation with the MELD score and MELD-Na Score. Correlation between MRE and ALBI grade was superior to T1 and T2 relaxometry methods. MRE performed better than T1 and T2 relaxometry to predict the presence of varices at endoscopy. On multivariate analyses, spleen length and MRE were the only two significant independent predictors of endoscopic varices.

Entities:  

Keywords:  Liver function; MR elastography (MRE); Portal hypertension; T1 mapping; T2 mapping

Year:  2020        PMID: 32274552     DOI: 10.1007/s00261-020-02432-7

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  33 in total

1.   Report of the Baveno VI Consensus Workshop.

Authors:  Andres Cardenas; Angela Mendez-Bocanegra
Journal:  Ann Hepatol       Date:  2016 Mar-Apr       Impact factor: 2.400

2.  Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2015-06-03       Impact factor: 25.083

Review 3.  Transjugular liver biopsy.

Authors:  Michel Ble; Bogdan Procopet; Rosa Miquel; Virginia Hernandez-Gea; Juan Carlos García-Pagán
Journal:  Clin Liver Dis       Date:  2014-08-30       Impact factor: 6.126

4.  Validating the Baveno VI recommendations for screening varices.

Authors:  Salvador Augustin; Mónica Pons; Joan Genesca
Journal:  J Hepatol       Date:  2016-11-05       Impact factor: 25.083

Review 5.  Portal Hypertension and Related Complications: Diagnosis and Management.

Authors:  Douglas A Simonetto; Mengfei Liu; Patrick S Kamath
Journal:  Mayo Clin Proc       Date:  2019-04       Impact factor: 7.616

6.  Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis.

Authors:  Rahul Rustogi; Jeanne Horowitz; Carla Harmath; Yi Wang; Hamid Chalian; Daniel R Ganger; Zongming E Chen; Bradley D Bolster; Saurabh Shah; Frank H Miller
Journal:  J Magn Reson Imaging       Date:  2012-01-13       Impact factor: 4.813

7.  Multiple biopsy passes and the risk of complications of percutaneous liver biopsy.

Authors:  Heng Chi; Bettina E Hansen; Wing Yin Tang; Jeoffrey N L Schouten; Dave Sprengers; Pavel Taimr; Harry L A Janssen; Robert J de Knegt
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-01       Impact factor: 2.566

8.  Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.

Authors:  Philip J Johnson; Sarah Berhane; Chiaki Kagebayashi; Shinji Satomura; Mabel Teng; Helen L Reeves; James O'Beirne; Richard Fox; Anna Skowronska; Daniel Palmer; Winnie Yeo; Frankie Mo; Paul Lai; Mercedes Iñarrairaegui; Stephen L Chan; Bruno Sangro; Rebecca Miksad; Toshifumi Tada; Takashi Kumada; Hidenori Toyoda
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544

9.  Model for end-stage liver disease (MELD) and allocation of donor livers.

Authors:  Russell Wiesner; Erick Edwards; Richard Freeman; Ann Harper; Ray Kim; Patrick Kamath; Walter Kremers; John Lake; Todd Howard; Robert M Merion; Robert A Wolfe; Ruud Krom
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

10.  Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function.

Authors:  Atsushi Hiraoka; Kojiro Michitaka; Takashi Kumada; Namiki Izumi; Masumi Kadoya; Norihiro Kokudo; Shoji Kubo; Yutaka Matsuyama; Osamu Nakashima; Michiie Sakamoto; Tadatoshi Takayama; Takashi Kokudo; Kosuke Kashiwabara; Masatoshi Kudo
Journal:  Liver Cancer       Date:  2017-09-22       Impact factor: 11.740

View more
  5 in total

Review 1.  Magnetic Resonance Elastography for the Clinical Risk Assessment of Fibrosis, Cirrhosis, and Portal Hypertension in Patients With NAFLD.

Authors:  Yamini Natarajan; Rohit Loomba
Journal:  J Clin Exp Hepatol       Date:  2021-08-08

2.  Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis.

Authors:  Sona Frankova; Mariia Lunova; Halima Gottfriedova; Renata Senkerikova; Magdalena Neroldova; Jozef Kovac; Eva Kieslichova; Vera Lanska; Petr Urbanek; Julius Spicak; Milan Jirsa; Jan Sperl
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

3.  Prediction of Hepatocellular Carcinoma by Liver Stiffness Measurements Using Magnetic Resonance Elastography After Eradicating Hepatitis C Virus.

Authors:  Takashi Kumada; Hidenori Toyoda; Satoshi Yasuda; Yasuhiro Sone; Sadanobu Ogawa; Kenji Takeshima; Toshifumi Tada; Takanori Ito; Yoshio Sumida; Junko Tanaka
Journal:  Clin Transl Gastroenterol       Date:  2021-04-23       Impact factor: 4.396

4.  Portal hypertension is the main driver of liver stiffness in advanced liver cirrhosis.

Authors:  M Lunova; S Frankova; H Gottfriedova; R Senkerikova; M Neroldova; J Kovac; E Kieslichova; V Lanska; E Sticova; J Spicak; M Jirsa; J Sperl
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

5.  Synthetic extracellular volume fraction without hematocrit sampling for hepatic applications.

Authors:  Narine Mesropyan; Patrick Kupczyk; Alexander Isaak; Christoph Endler; Anton Faron; Leona Dold; Alois M Sprinkart; Claus C Pieper; Daniel Kuetting; Ulrike Attenberger; Julian A Luetkens
Journal:  Abdom Radiol (NY)       Date:  2021-06-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.